SER-155

· Seres Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SER-155, covering 2024-10-01 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SER-155 to Treat Diarrhea in People on Immunotherapy [Phase 1]